1609P Cannabis impacts on serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer

Detalles Bibliográficos
Autores principales: Zer, A., Goshen-Lago, T.G., Ben-Aharon, I., Passhak, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472520/
http://dx.doi.org/10.1016/j.annonc.2022.07.1702
_version_ 1784789319653785600
author Zer, A.
Goshen-Lago, T.G.
Ben-Aharon, I.
Passhak, M.
author_facet Zer, A.
Goshen-Lago, T.G.
Ben-Aharon, I.
Passhak, M.
author_sort Zer, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9472520
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-94725202022-09-14 1609P Cannabis impacts on serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer Zer, A. Goshen-Lago, T.G. Ben-Aharon, I. Passhak, M. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-09 2022-09-13 /pmc/articles/PMC9472520/ http://dx.doi.org/10.1016/j.annonc.2022.07.1702 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Zer, A.
Goshen-Lago, T.G.
Ben-Aharon, I.
Passhak, M.
1609P Cannabis impacts on serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer
title 1609P Cannabis impacts on serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer
title_full 1609P Cannabis impacts on serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer
title_fullStr 1609P Cannabis impacts on serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer
title_full_unstemmed 1609P Cannabis impacts on serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer
title_short 1609P Cannabis impacts on serologic status and toxic effects of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing treatment for cancer
title_sort 1609p cannabis impacts on serologic status and toxic effects of the sars-cov-2 bnt162b2 vaccine in patients undergoing treatment for cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472520/
http://dx.doi.org/10.1016/j.annonc.2022.07.1702
work_keys_str_mv AT zera 1609pcannabisimpactsonserologicstatusandtoxiceffectsofthesarscov2bnt162b2vaccineinpatientsundergoingtreatmentforcancer
AT goshenlagotg 1609pcannabisimpactsonserologicstatusandtoxiceffectsofthesarscov2bnt162b2vaccineinpatientsundergoingtreatmentforcancer
AT benaharoni 1609pcannabisimpactsonserologicstatusandtoxiceffectsofthesarscov2bnt162b2vaccineinpatientsundergoingtreatmentforcancer
AT passhakm 1609pcannabisimpactsonserologicstatusandtoxiceffectsofthesarscov2bnt162b2vaccineinpatientsundergoingtreatmentforcancer

Ejemplares similares